Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers

NCT02989961 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Foot Ulcer

Interventions

OTHER: Resticutis
OTHER: Platelet-Poor Plasma (PPP)

Sponsor

Hanan Jafar